Serum neurofilament light-chain (sNfL) levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (RRMS) patients in the CombiRx trial

被引：0
|
作者：
Cutter, Gary [1 ]
Rudick, Richard A. [2 ]
De Moor, Carl [2 ]
Singh, Carol M. [2 ]
Fisher, Elizabeth [2 ]
Lublin, Fred D. [3 ,4 ]
Wolinsky, Jerry S. [5 ]
McFarland, Henry [6 ]
Jacobson, Steven [7 ]
Naylor, Maria L. [2 ]
机构：
[1] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[2] Biogen, Cambridge, MA USA
[3] Icahn Sch Med Mt Sinai, Dept Neurol, Corinne Goldsmith Dickinson Ctr Multiple Scleros, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA
[5] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[6] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA
[7] Natl Inst Neurol Disorders & Stroke, Viral Immunol Sect, NIH, Bethesda, MD USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2410
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (rrms) patients in the combirx trial
    Cutter, G.
    Rudick, R.
    De Moor, C.
    Singh, C.
    Fisher, E.
    Lublin, F.
    Wolinsky, J.
    Mcfarland, H.
    Jacobson, S.
    Kieseier, B.
    Naylor, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 193 - 193
  • [2] Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial
    Cutter, Gary
    Rudick, Richard A.
    de Moor, Carl
    Singh, Carol M.
    Fisher, Elizabeth
    Koster, Thijs
    Lublin, Fred D.
    Wolinsky, Jerry S.
    McFarland, Henry
    Jacobson, Steven
    Naylor, Maria L.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (02)
  • [3] Long-term Effect of Fingolimod in Reducing Blood Neurofilament Light Levels in Patients with Relapsing-remitting Multiple Sclerosis
    Cohen, Jeffrey
    Kappos, Ludwig
    Tenenbaum, Nadia
    Han, Jackie
    Kropshofer, Harald
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2019, 92 (15)
  • [4] Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
    Kuhle, Jens
    Disanto, Giulio
    Lorscheider, Johannes
    Stites, Tracy
    Chen, Yu
    Dahlke, Frank
    Francis, Gordon
    Shrinivasan, Anupama
    Radue, Ernst-Wilhelm
    Giovannoni, Gavin
    Kappos, Ludwig
    NEUROLOGY, 2015, 84 (16) : 1639 - 1643
  • [5] Serum neurofilament in patients with relapsing-remitting multiple sclerosis
    Brandt, A. U.
    Paul, F.
    Freing, A.
    Oberwahrenbrock, T.
    Petzold, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S269 - S270
  • [6] Dimethyl fumarate decreases serum neurofilament light chain in relapsing-remitting multiple sclerosis patients
    Sainz De La Maza, S.
    Walo Delgado, P. E.
    Villarrubia, N.
    Monreal, E.
    Espino, M.
    Fernandez-Velasco, J. I.
    Masjuan, J.
    Costa-Frossard, L.
    Villar, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 149 - 150
  • [7] Quantitative assessment of thalamic damage and serum neurofilament light chain in relapsing-remitting multiple sclerosis
    Liang, Yan
    Huang, Jing
    Zhang, Xiyue
    Xu, Fang
    Bo, Chunrui
    Lin, Ming
    Wen, Xinmei
    JOURNAL OF NEUROIMMUNOLOGY, 2025, 399
  • [8] COMPARISON OF OREXIN-A AND NEUROFILAMENT LIGHT CHAIN LEVELS IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: A PILOT STUDY
    Saruhan, Ercan
    Korkmaz, Muammer
    Altiparmak, Basak
    Tosun, Kursad
    Kutlu, Gulnihal
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (7-8): : 223 - 230
  • [9] An integral measure of serial neurofilament light chain assessments in blood is a predictor of long-term disability progression in relapsing-remitting multiple sclerosis
    Kuhle, J.
    Cohen, J.
    Haring, D. A.
    Kropshofer, H.
    Leppert, D.
    Tomic, D.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 695 - 696
  • [10] Serum and CSF Neurofilament Light Levels Predict Long-Term Outcomes in Multiple Sclerosis Patients
    Kuhle, Jens
    Plavina, Tatiana
    Barro, Christian
    Sangurdekar, Dipen
    Singh, Carol
    DeMoor, Carl
    Engle, Bob
    Fisher, Elizabeth
    Kappos, Ludwig
    Rudick, Richard
    Goyal, Jaya
    NEUROLOGY, 2017, 88
12345